• Gupta A. Silman AJ. Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther 2004;6:98-106.
• Fitzcharles MA. Ste-Marie PA. Goldenberg DL. Pereira JX. et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag 2013;18:119-26.
• Yunus MB. Khan MA. Rawlings KK. Green JR. et al. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999;26:408-12.
• Weinberger LM. Traumatic fibromyositis: a critical review of an enigmatic concept. West J Med 1997;127:99-103.
• Gur A. Karakoç M, Nas K, et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol 2002; 29: 358-61.
• Goldenberg DL. Fibromyalgia and its relation to chronic fatigue syndrome. viral illness and immune abnormalities. J Rheumatol Suppl 1989;19:91-3.
• Gur A. Karakoc M. Erdogan S. Nas K. et al. Regional blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002;20:753-60.
• Salemi S, Rethage J, Wollina U, et al. Detection of interleukin 1ß (IL-1ß). IL-6. and tumor necrosis factor- α in skin of patients with fibromyalgia. J Rheumatol 2003;30:146-50.
• Su SY, Chen JJ, Lai CC, Chen CM, et al. The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 2007;26:12-6.
• Uçeyler N, Valenza R, Stock M, Schedel R, et al. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006;54:2656-64.
• Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-53.
• Cohen H, Neumann L, Shore M, Amir M, et al. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000;29:217-27.
• Rowe PC, Bou Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognized cause of chronic fatigue? Lancet 1995;345:623-4.
• Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, et al. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 2000;43:872-80.
• Scott LV, Teh J, Reznek R, Martin A, et al. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999;24:759-68.
• Celikbilek M, Dogan S, Ozbakır O, Zararsız G, et al. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 2013;27:72-6.
• Imtiaz F, Shafique K, Mirza SS, Ayoob Z, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in preva¬lent chronic diseases in Asian population. Int Arch Med 2012;5:2.
• Tousoulis D, Antoniades C, Koumallos N, Stefanadis C. Proinflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 2006;17:225-33.
• Zahorec R. Ratio of neutrophil to lymphocyte counts Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.
• Proctor MJ, Morrison DS, Talwar D, Balmer SM, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 2011;47:2633-41.
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
• Gibson PH, Cuthbertson BH, Croal BL, Rae D, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery baypass grafting. Am J Cardiol 2010;105:186-91.
• Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638–43.
• Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482–94.
• Tamhane UU, Aneja S, Montgomery D, Rogers EK, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653-7.
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictor of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-90.
• Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, et al. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 2012;23:265-73.
• Azab B, Shah N, Radbel J, Tan P, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013;30:432
• Lai Q, Castro Santa E, Rico Juri JM, Pinheiro RS, et al. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. Transpl Int 2014;27(1):32-41.
• Uslu AU, Deveci K, Korkmaz S, Aydin B, et al. Is neutrophil/lym¬phocyterati oassociated with subclinical inflam¬mation andamyloidosis in patients with familial¬Mediterranean fever? Biomed Res Int 2013;2013: 185317
• Ahsen A, Ulu MS, Yuksel S, Demir K, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 2013; 36:1357-62.
• Boyraz I, Koç B, Boyacı A, Tutoğlu A, et al. Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. Int J Clin Exp Med 2014;7(9):2912-5

Vancouver

İlgün E, Akyürek Ö, Kalkan AO, Demir F, Demirayak M, Bilgi M. Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia. EUR J GEN MED. 2016;13(2):100-4. https://doi.org/10.15197/ejgm.1525

APA

İlgün, E., Akyürek, Ö., Kalkan, A. O., Demir, F., Demirayak, M., & Bilgi, M. (2016). Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia. European Journal of General Medicine, 13(2), 100-104. https://doi.org/10.15197/ejgm.1525

AMA

İlgün E, Akyürek Ö, Kalkan AO, Demir F, Demirayak M, Bilgi M. Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia. EUR J GEN MED. 2016;13(2), 100-104. https://doi.org/10.15197/ejgm.1525

Chicago

İlgün, Erdem, Ömer Akyürek, Ali Osman Kalkan, Fethi Demir, Mehmet Demirayak, and Mustafa Bilgi. "Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia". European Journal of General Medicine 2016 13 no. 2 (2016): 100-104. https://doi.org/10.15197/ejgm.1525

Harvard

İlgün, E., Akyürek, Ö., Kalkan, A. O., Demir, F., Demirayak, M., and Bilgi, M. (2016). Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia. European Journal of General Medicine, 13(2), pp. 100-104. https://doi.org/10.15197/ejgm.1525

MLA

İlgün, Erdem et al. "Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Fibromyalgia". European Journal of General Medicine, vol. 13, no. 2, 2016, pp. 100-104. https://doi.org/10.15197/ejgm.1525